Search Results for "Servier Sweden"
Original Source: Sweden
The Scandinavian country of Sweden is home to a thriving biotechnology industry, one of the top 5 in Europe. Europe has become a global center for the industry, helped by €2 billion worth of funds from the European Federation of Pharmaceutical Indus...
Matching Channels
The Scandinavian country of Sweden is home to a thriving biotechnology industry, one of the top 5 in Europe. Europe has become a global center for the industry, helped by €2 billion worth of fu...
The Top 100 Pharmaceutical Companies
The Top 100 Pharmaceutical Companies, determined by total sales in 2011 - see below for 2010 and 2009: They are listed in descending order with the sales in 2011 in $ million; Pfizer ...
Matching News
Servier is a top pharmaceutical company based in Suresnes, France. Servier was founded in 1954, and is the first independent pharmaceutical group in France. Servier is a global pharmaceutical company...
At home with Servier Servier's drugs Servier's portfolio of marketed drugs is dominated by products for cardiovascular indications. The company is hoping to add more cancer drugs in the next two or th...
Servier, a top pharmaceutical company, is reviewed in terms of partnering and licensing interests and activity over recent years. Return to top 50 pharma list Summary Website: Servier Headquarters: Su...
Boehringer, Servier sign gevokizumab manufacturing agreement
Boehringer Ingelheim has signed a manufacturing agreement with Servier and its partner XOMA to produce gevokizumab at its facility in Biberach, Germany, for Servier's commercial use.
Servier Founder Faces Charges In Mediator Scandal
In a rare move not seen in the pharmaceutical industry, Jacques Servier, who founded Servier Laboratories, was formally placed under investigation on suspicion of manslaughter in connection with his r...
Latest News From "The Pink Sheet" DAILY - NICE Backs Servier's Procolaran
NICE Backing For Procolaran In CHF May Prove Lucrative For Servier If NICE's backing for Servier's heart drug Procolaran does spread across Europe, then the resulting returns may offset some of financ...
Afraxis and Servier collaborate on CNS disorder drug discovery
Privately-held US firm Afraxis and the Institut de Recherches Servier, a part of independent French drugmaker Laboratoires Servier, have entered into a non-exclusive platform collaboration using Afrax...
NovAliX and Servier collaborate in early drug discovery research program
NovAliX has entered into drug discovery collaboration with the pharmaceutical company Servier. Under the terms of this agreement Graffinity, a NovAliX subsidiary, will be responsible for the discovery...
Matching PubMed Articles
Deal watch: XOMA and Servier to develop anti-IL-1β antibody for inflammatory diseases.
Introduction to the special issue on High Resolution Pharmacology.
We have developed biochemical and cell based assays to characterize small therapeutic molecules that inhibit the DNA damage checkpoint enzyme, Chk1 (Checkpoint kinase 1).
